SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SPNT • BMG8192H1060

20.19 USD
-0.25 (-1.22%)
At close: Feb 3, 2026
20.19 USD
0 (0%)
After Hours: 2/3/2026, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPNT. SPNT was compared to 147 industry peers in the Insurance industry. Both the profitability and financial health of SPNT have multiple concerns. SPNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SPNT had positive earnings in the past year.
  • SPNT had a positive operating cash flow in the past year.
  • Of the past 5 years SPNT 4 years were profitable.
  • In the past 5 years SPNT always reported a positive cash flow from operatings.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

  • SPNT has a Return On Assets (1.49%) which is in line with its industry peers.
  • With a Return On Equity value of 8.39%, SPNT perfoms like the industry average, outperforming 40.82% of the companies in the same industry.
  • The Return On Invested Capital of SPNT (2.65%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROIC 2.65%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • The Profit Margin of SPNT (6.49%) is worse than 60.54% of its industry peers.
  • In the last couple of years the Profit Margin of SPNT has declined.
  • The Operating Margin of SPNT (13.29%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SPNT has declined.
Industry RankSector Rank
OM 13.29%
PM (TTM) 6.49%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPNT is destroying value.
  • SPNT has less shares outstanding than it did 1 year ago.
  • SPNT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SPNT has been reduced compared to a year ago.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • The Debt to FCF ratio of SPNT is 3.21, which is a good value as it means it would take SPNT, 3.21 years of fcf income to pay off all of its debts.
  • SPNT has a Debt to FCF ratio (3.21) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that SPNT is not too dependend on debt financing.
  • SPNT's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. SPNT outperforms 51.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Altman-Z N/A
ROIC/WACC0.3
WACC8.74%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

  • The earnings per share for SPNT have decreased by 0.00% in the last year.
  • Measured over the past years, SPNT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.97% on average per year.
  • The Revenue has been growing slightly by 2.43% in the past year.
  • Measured over the past years, SPNT shows a very strong growth in Revenue. The Revenue has been growing by 22.87% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, SPNT will show a small growth in Revenue. The Revenue will grow by 3.67% on average per year.
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue Next Year-2.66%
Revenue Next 2Y2.38%
Revenue Next 3Y3.67%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.70, SPNT is valued correctly.
  • The rest of the industry has a similar Price/Earnings ratio as SPNT.
  • SPNT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.18.
  • The Price/Forward Earnings ratio is 8.11, which indicates a very decent valuation of SPNT.
  • Based on the Price/Forward Earnings ratio, SPNT is valued a bit cheaper than 68.71% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SPNT to the average of the S&P500 Index (25.51), we can say SPNT is valued rather cheaply.
Industry RankSector Rank
PE 12.7
Fwd PE 8.11
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 68.03% of the companies in the same industry are more expensive than SPNT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 11.08
EV/EBITDA 6.28
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SPNT's earnings are expected to grow with 43.31% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y61.01%
EPS Next 3Y43.31%

0

5. Dividend

5.1 Amount

  • No dividends for SPNT!.
Industry RankSector Rank
Dividend Yield 0%

SIRIUSPOINT LTD

NYSE:SPNT (2/3/2026, 8:04:00 PM)

After market: 20.19 0 (0%)

20.19

-0.25 (-1.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners87.28%
Inst Owner Change-0.09%
Ins Owners1.59%
Ins Owner Change-6.84%
Market Cap2.36B
Revenue(TTM)2.86B
Net Income(TTM)185.50M
Analysts82.5
Price Target22.95 (13.67%)
Short Float %1.68%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP8.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.28%
Min EPS beat(2)-13.77%
Max EPS beat(2)40.33%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-131.86%
Max EPS beat(4)108.87%
EPS beat(8)5
Avg EPS beat(8)14.3%
EPS beat(12)8
Avg EPS beat(12)37.79%
EPS beat(16)9
Avg EPS beat(16)12%
Revenue beat(2)1
Avg Revenue beat(2)1.95%
Min Revenue beat(2)-9.34%
Max Revenue beat(2)13.24%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-8.18%
EPS NY rev (1m)0%
EPS NY rev (3m)32.6%
Revenue NQ rev (1m)4.21%
Revenue NQ rev (3m)4.21%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 12.7
Fwd PE 8.11
P/S 0.82
P/FCF 11.08
P/OCF 11.08
P/B 1.07
P/tB 1.13
EV/EBITDA 6.28
EPS(TTM)1.59
EY7.88%
EPS(NY)2.49
Fwd EY12.33%
FCF(TTM)1.82
FCFY9.03%
OCF(TTM)1.82
OCFY9.03%
SpS24.47
BVpS18.92
TBVpS17.86
PEG (NY)0.08
PEG (5Y)N/A
Graham Number26.02
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 8.39%
ROCE 3.06%
ROIC 2.65%
ROICexc 2.78%
ROICexgc 3.78%
OM 13.29%
PM (TTM) 6.49%
GM N/A
FCFM 7.45%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.21
Debt/EBITDA 1.74
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 54.38%
Profit Quality 114.77%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.74%
ROIC/WACC0.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%2333.33%
EPS Next Y155%
EPS Next 2Y61.01%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue 1Y (TTM)2.43%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%15.21%
Revenue Next Year-2.66%
Revenue Next 2Y2.38%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y-22.34%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.16%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-51.16%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%

SIRIUSPOINT LTD / SPNT FAQ

What is the fundamental rating for SPNT stock?

ChartMill assigns a fundamental rating of 4 / 10 to SPNT.


What is the valuation status for SPNT stock?

ChartMill assigns a valuation rating of 6 / 10 to SIRIUSPOINT LTD (SPNT). This can be considered as Fairly Valued.


Can you provide the profitability details for SIRIUSPOINT LTD?

SIRIUSPOINT LTD (SPNT) has a profitability rating of 3 / 10.


How financially healthy is SIRIUSPOINT LTD?

The financial health rating of SIRIUSPOINT LTD (SPNT) is 3 / 10.


What is the earnings growth outlook for SIRIUSPOINT LTD?

The Earnings per Share (EPS) of SIRIUSPOINT LTD (SPNT) is expected to grow by 155% in the next year.